恒瑞医药鲁兹诺雷钠片获批；赛诺医疗递交H股上市申请｜医药早参

每日经济新闻05-29 07:00

｜ 2026年5月29日星期五｜　　NO.1 石药集团+康宁杰瑞：安尼妥单抗注射液正式获批上市　　石药集团（HK01093）康宁杰瑞（HK09966）5月28日披露，双方联合研发的安尼妥单抗注射液获NMPA批准上市，适应证为联合化疗治疗既往经曲妥珠单抗治疗失败的HER2阳性晚期胃癌/胃食管结合部腺癌。　　点评：安尼妥单抗获批上市，补齐国内HER2阳性晚期胃癌后线治疗用药选择，两家企业核心管线迎来...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2639142226?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-29 07:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639142226","market":"us","top_or_hot":-1,"title":"恒瑞医药鲁兹诺雷钠片获批；赛诺医疗递交H股上市申请｜医药早参","media":"每日经济新闻","content":"<div>\n<p>｜ 2026年5月29日星期五 ｜　　NO.1 石药集团+康宁杰瑞：安尼妥单抗注射液正式获批上市　　石药集团（HK01093）康宁杰瑞（HK09966）5月28日披露，双方联合研发的安尼妥单抗注射液获NMPA批准上市，适应证为联合化疗治疗既往经曲妥珠单抗治疗失败的HER2阳性晚期胃癌/胃食管结合部腺癌。　　点评：安尼妥单抗获批上市，补齐国内HER2阳性晚期胃癌后线治疗用药选择，两家企业核心管线迎来...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202605293753219246.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药鲁兹诺雷钠片获批；赛诺医疗递交H股上市申请｜医药早参</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药鲁兹诺雷钠片获批；赛诺医疗递交H股上市申请｜医药早参\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-29 07:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202605293753219246.html><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>｜ 2026年5月29日星期五 ｜　　NO.1 石药集团+康宁杰瑞：安尼妥单抗注射液正式获批上市　　石药集团（HK01093）康宁杰瑞（HK09966）5月28日披露，双方联合研发的安尼妥单抗注射液获NMPA批准上市，适应证为联合化疗治疗既往经曲妥珠单抗治疗失败的HER2阳性晚期胃癌/胃食管结合部腺癌。　　点评：安尼妥单抗获批上市，补齐国内HER2阳性晚期胃癌后线治疗用药选择，两家企业核心管线迎来...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202605293753219246.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2097828631.EUR","symbol_name":"AZ EQUITY CHINA \"A\" (EUR) ACC","start_time":0,"source_url":"http://finance.eastmoney.com/a/202605293753219246.html","article_id":"2639142226","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605293753219246.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2639142226","pubTimestamp":1780009204,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"｜2026年5月29日星期五｜NO.1石药集团+康宁杰瑞：安尼妥单抗注射液正式获批上市石药集团（HK01093）康宁杰瑞（HK09966）5月28日披露，双方联合研发的安尼妥单抗注射液获NMPA批准上市，适应证为联合化疗治疗既往经曲妥珠单抗治疗失败的HER2阳性晚期胃癌/胃食管结合部腺癌。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","600276":"恒瑞医药","688108":"赛诺医疗","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","LU2580892862.HKD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (HKD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","LU1146622755.USD":"安本中国A股股票基金A Acc","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念","IPOS":"Renaissance International IPO ETF","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","09939":"开拓药业-B","BK0251":"专用设备","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0028":"国家队","BK1191":"制药","01276":"恒瑞医药","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","BK1161":"生物科技","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","BK0060":"抗癌","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU0359201612.USD":"贝莱德中国基金A2","LU1997245177.USD":"安联神洲A股基金","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","BK1515":"抗疫概念","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","BK0196":"行业龙头","BK1574":"生物医药B类股","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU1255011170.USD":"JPM CHINA A-SHARE OPPORTUNITIES \"A\" (USD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","BK0239":"医药制造"},"translate_title":"Hengrui Medicine Luznorel Sodium Tablets were approved; Sano Medical Submits H Share Listing Application | Pharmaceutical Morning Ginseng","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1.5,"600276":1.5,"688108":1.5,"IPOS":1.5,"01276":1.5,"09939":1.5},"content_text":"｜ 2026年5月29日星期五 ｜　　NO.1 石药集团+康宁杰瑞：安尼妥单抗注射液正式获批上市　　石药集团（HK01093）康宁杰瑞（HK09966）5月28日披露，双方联合研发的安尼妥单抗注射液获NMPA批准上市，适应证为联合化疗治疗既往经曲妥珠单抗治疗失败的HER2阳性晚期胃癌/胃食管结合部腺癌。　　点评：安尼妥单抗获批上市，补齐国内HER2阳性晚期胃癌后线治疗用药选择，两家企业核心管线迎来商业化兑现节点，将直接重塑国内胃癌靶向治疗市场竞争格局。　　NO.2 恒瑞医药：鲁兹诺雷钠片获批，国产首个URAT1抑制剂痛风药　　恒瑞医药（SH600276）5月28日公告，公司鲁兹诺雷钠片（瑞鸣）获国家药监局批准上市，用于高尿酸血症及痛风患者降尿酸治疗，系国内首款自主研发的URAT1靶点创新药。　　点评：该产品上市填补国产URAT1抑制剂领域空白，对标进口非布司他，直面超3600万痛风患者市场。叠加当日股价异动，利好兑现后市场预期出现分歧，具备较强市场话题度。　　NO.3 派格生物：GLP1周制剂维培那肽纳入医保参照药预沟通名单　　派格生物（HK02565）5月28日披露，核心产品每周一次长效GLP1制剂维培那肽注射液，被纳入2026年第二批医保参照药预沟通增补清单，为后续正式纳入医保目录奠定基础。　　点评：在GLP1赛道白热化竞争背景下，医保准入是国产减重降糖药商业化落地的核心抓手，本次纳入预沟通名单，是维培那肽商业化进程中的关键一步，赛道医保博弈节奏进一步提速。　　NO.4 赛诺医疗正式递交H股上市申请　　赛诺医疗（SH688108）5月28日对外公告，公司已于5月27日向港交所递交主板上市申请，拟募集资金用于介入医疗器械研发投入与产能扩建。　　点评：作为国产高端心脑血管介入器械龙头，公司冲刺港股上市，为器械企业拓宽融资渠道，也标志着心脑血管赛道再添重要IPO标的，行业资本关注度持续提升。　　NO.5 复星医药：控股子公司联合设立10亿元生物医药基金　　复星医药（SH600196，HK02196）5月28日公告，控股子公司苏州君明联合多方发起设立杭州生物医药基金，基金总规模10亿元，首轮募集8亿元，资金重点投向创新药、医疗器械、医疗服务等领域。　　点评：复星医药加码生物医药产业基金，是其产业资本布局的重要动作，既可以通过投资孵化优质标的、反哺上市公司管线，也释放出产业资本持续看好创新医药赛道的积极信号。（文章来源：每日经济新闻）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639142226","isCrawlerRequest":true}